Biosynthesis of Recombinant Vaccines in Plant Expression Systems

被引：0

作者：

Uvarova, E. A. ^{[1
]}

Belavin, P. A. ^{[1
]}

Permyakova, N. V. ^{[1
]}

Deineko, E. V. ^{[1
]}

机构：

[1] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk, Russia

来源：

RUSSIAN JOURNAL OF PLANT PHYSIOLOGY | 2024年 / 71卷 / 05期

关键词：

recombinant subunit vaccines; immunity; plant expression systems; edible vaccines; VIRUS-LIKE PARTICLES; THERAPEUTIC VACCINES; INFLUENZA VACCINE; EDIBLE VACCINE; CORE PARTICLES; CAPSID PROTEIN; IMMUNOGENICITY; ANTIGEN; EFFICACY; BIOTECHNOLOGY;

D O I：

10.1134/S1021443724607778

中图分类号：

Q94 [植物学];

学科分类号：

071001 ;

摘要：

The advances in genetic engineering have led to the emergence of a new branch of vaccinology-the development of recombinant subunit vaccines that initiate the formation of protective immunity against various diseases. One of the promising and actively developing systems for the expression of recombinant proteins for medical purposes are plants. This review provides a general overview of the formation of specific and nonspecific immunity, the functioning of humoral and cellular immunity, and the principles of creating recombinant vaccines. The development of vaccines for the prevention of such infections as influenza, coronaviruses, human papillomavirus, hepatitis B virus, and noroviruses is considered in more detail, with examples of plant-derived recombinant proteins that prevent these diseases. The market for recombinant plant-based vaccines is assessed and examples of the most successful ones are given. Overall, the review aims to highlight the relevance of plant expression systems for the development of recombinant vaccine preparations and their potential for rapid response to emerging challenges in the field of infectious disease prevention.

引用

页数：15

共 98 条

[1] An overview on medicinal plants used for combating coronavirus: Current potentials and challenges [J].

Abou Baker, Doha H. ;

Hassan, Emad M. ;

El Gengaihi, Souad .

JOURNAL OF AGRICULTURE AND FOOD RESEARCH, 2023, 13

[2] Pathogen recognition and innate immunity [J].

Akira, S ;

Uematsu, S ;

Takeuchi, O .

CELL, 2006, 124 (04) :783-801

[3]

[Anonymous], Global Vaccine Action Plan

[4]

[Anonymous], Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process

[5]

Barnabas Ruanne V, 2022, NEJM Evid, V1, pEVIDoa2100056, DOI 10.1056/EVIDoa2100056

[6] Plant-Produced Recombinant Influenza A Virus Candidate Vaccine Based on Flagellin Linked to Conservative Fragments of M2 Protein and Hemagglutintin [J].

Blokhina, Elena A. ;

Mardanova, Eugenia S. ;

Stepanova, Liudmila A. ;

Tsybalova, Liudmila M. ;

Ravin, Nikolai V. .

PLANTS-BASEL, 2020, 9 (02)

[7]

Brocke P., Production of Recombinant Proteins: Novel Microbial and Eukaryotic Expression Systems

[8] Envelopment of the hepatitis B virus nucleocapsid [J].

Bruss, V .

VIRUS RESEARCH, 2004, 106 (02) :199-209

[9] Potential Applications of Plant Biotechnology against SARS-CoV-2 [J].

Capell, Teresa ;

Twyman, Richard M. ;

Armario-Najera, Victoria ;

Ma, Julian K. -C. ;

Schillberg, Stefan ;

Christou, Paul .

TRENDS IN PLANT SCIENCE, 2020, 25 (07) :635-643

[10] Therapeutic vaccines for high-risk HPV-associated diseases [J].

Chabeda, Aleyo ;

Yanez, Romana J. R. ;

Lamprecht, Renate ;

Meyers, Ann E. ;

Rybicki, Edward P. ;

Hitzeroth, Inga I. .

PAPILLOMAVIRUS RESEARCH, 2018, 5 :46-58

← 1 2 3 4 5 6 7 8 9 10 →